{"DataElement":{"publicId":"3233414","version":"1","preferredName":"MIB1 Level Positive Percentage Range","preferredDefinition":"Numeric value to represent the percentage range of MIB-1 positive cells thru immunophenotypic analysis.","longName":"2178383v1.0:3233403v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2178383","version":"1","preferredName":"MIB1 Level","preferredDefinition":"Level of a cell cycle and tumor growth marker which can be readily detected using immunocytochemistry methods.","longName":"MIB1_LVL","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2178381","version":"1","preferredName":"Proliferation-Related Ki-67 Antigen","preferredDefinition":"A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.","longName":"MKI67","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Antigen KI-67","conceptCode":"C17675","definition":"Antigen KI-67 protein (3256 aa, ~359 kDa) is encoded by the human MKI67 gene. This protein is required for cell proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC571B25-1D51-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"updated to add EVS concept code and long name - dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177479","version":"1","preferredName":"Level","preferredDefinition":"Level; a position on a scale of intensity or amount or quality.","longName":"Level","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Level","conceptCode":"C25554","definition":"A position on a scale measuring intensity, quality, or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5228-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC571B25-1D56-4065-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3233403","version":"1","preferredName":"MIB-1 Positive Percentage Range","preferredDefinition":"Antigen Identified by Monoclonal Antibody Ki-67, encoded by the MKI67 gene, is a nuclear antigen expressed in proliferating cells but not in quiescent cells, and required for maintaining cell proliferation. Expression of this antigen occurs preferentially during late G1, S, G2, and M phases of the cell cycle, while in cells in G0 phase the antigen cannot be detected. Consequently, the monoclonal antibody Ki-67 is used in tumor pathology to detect proliferating cells in neoplastic diseases. This antigen is located in the nucleus, predominantly localized in the G1 phase in the perinucleolar region. In the later phases it is also detected throughout the nuclear interior, being predominantly localized in the nuclear matrix. In mitosis, it is present on all chromosomes. This antigen contains 1 FHA domain. Two alternative splicing forms exist, Long and Short. (from Swiss-Prot)_Involving advantage or good._Percentage; a fraction or ratio with 100 understood as the denominator._The difference between the lowest and highest numerical values; the limits or scale of variation.","longName":"3233403v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","unitOfMeasure":"%","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"76 - 100%","valueDescription":"76 - 100","ValueMeaning":{"publicId":"3233404","version":"1","preferredName":"76 - 100","longName":"3233404","preferredDefinition":"76 - 100","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A275399E-5AD2-DA09-E040-BB89AD436329","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A275399E-5AEB-DA09-E040-BB89AD436329","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"ONEDATA","dateModified":"2011-05-04","deletedIndicator":"No"},{"value":"51 - 75%","valueDescription":"51 - 75","ValueMeaning":{"publicId":"3233405","version":"1","preferredName":"51 - 75","longName":"3233405","preferredDefinition":"51 - 75","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A275399E-5AF5-DA09-E040-BB89AD436329","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A275399E-5B0E-DA09-E040-BB89AD436329","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"ONEDATA","dateModified":"2011-05-04","deletedIndicator":"No"},{"value":"26 - 50%","valueDescription":"26 - 50","ValueMeaning":{"publicId":"3233406","version":"1","preferredName":"26 - 50","longName":"3233406","preferredDefinition":"26 - 50","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A275399E-5B18-DA09-E040-BB89AD436329","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A275399E-5B31-DA09-E040-BB89AD436329","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"ONEDATA","dateModified":"2011-05-04","deletedIndicator":"No"},{"value":"0 - 25%","valueDescription":"0 - 25","ValueMeaning":{"publicId":"3233407","version":"1","preferredName":"0 - 25","longName":"3233407","preferredDefinition":"0 - 25","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A275399E-5B3B-DA09-E040-BB89AD436329","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A275399E-5B54-DA09-E040-BB89AD436329","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"ONEDATA","dateModified":"2011-05-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3233402","version":"1","preferredName":"Proliferation-Related Ki-67 Antigen Positive Percentage Range","preferredDefinition":"Antigen Identified by Monoclonal Antibody Ki-67, encoded by the MKI67 gene, is a nuclear antigen expressed in proliferating cells but not in quiescent cells, and required for maintaining cell proliferation. Expression of this antigen occurs preferentially during late G1, S, G2, and M phases of the cell cycle, while in cells in G0 phase the antigen cannot be detected. Consequently, the monoclonal antibody Ki-67 is used in tumor pathology to detect proliferating cells in neoplastic diseases. This antigen is located in the nucleus, predominantly localized in the G1 phase in the perinucleolar region. In the later phases it is also detected throughout the nuclear interior, being predominantly localized in the nuclear matrix. In mitosis, it is present on all chromosomes. This antigen contains 1 FHA domain. Two alternative splicing forms exist, Long and Short. (from Swiss-Prot) :Involving advantage or good.:Percentage; a fraction or ratio with 100 understood as the denominator.:The difference between the lowest and highest numerical values; the limits or scale of variation.","longName":"C17675:C25246:C25613:C38013","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antigen KI-67","conceptCode":"C17675","definition":"Antigen KI-67 protein (3256 aa, ~359 kDa) is encoded by the human MKI67 gene. This protein is required for cell proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Range","conceptCode":"C38013","definition":"The difference between the lowest and highest numerical values; the limits or scale of variation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A275399E-5AAA-DA09-E040-BB89AD436329","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"ONEDATA","dateModified":"2011-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A275399E-5ABB-DA09-E040-BB89AD436329","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"COOPERM","dateModified":"2011-05-12","changeDescription":"Released per approval by B. McClure-Shimel. mc 5/12/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"MIB-1 Positive Percentage Ran","type":"Preferred Question Text","description":"MIB-1 Positive Percentage Range","url":null,"context":"NCIP"},{"name":"CTSP Question","type":"Alternate Question Text","description":"Immunophenotyping MIB-1","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A275CA77-4777-E2C8-E040-BB89AD434F94","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-04","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Released per approval by B. McClure-Shimel. mc 5/12/11. 3/28/2017 added alt question text for CTSP task, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}